Great Novel Therapeutics Biotech & Medicals (TPEX:7427)
Taiwan · Delayed Price · Currency is TWD 31.00
-0.05 (-0.16%)
Mar 24, 2026, 1:34 PM CST
TPEX:7427 Market Cap
TPEX:7427 has a market cap or net worth of 1.33 billion as of March 24, 2026. Its market cap has decreased by -27.36% in one year.
Market Cap
1.33B
Enterprise Value
839.84M
Revenue
1.78M
Ranking
n/a
PE Ratio
n/a
Stock Price
31.00
Market Cap Chart
Since July 8, 2021, TPEX:7427's market cap has decreased from 1.48B to 1.33B, a decrease of -9.95%. That is a compound annual growth rate of -2.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 24, 2026 | 1.33B | -3.13% |
| Dec 31, 2025 | 1.37B | -7.37% |
| Dec 31, 2024 | 1.48B | -42.09% |
| Dec 29, 2023 | 2.56B | 40.55% |
| Dec 30, 2022 | 1.82B | 94.83% |
| Dec 30, 2021 | 935.73M | -36.72% |
| Jul 8, 2021 | 1.48B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Advagene Biopharma | 1.71B |
| TaiRx | 1.67B |
| GenMont Biotech Incorporation | 1.54B |
| NeoCore Technology | 1.43B |
| Abnova (Taiwan) | 1.40B |
| Enimmune | 1.31B |
| Meribank Biotech | 1.24B |
| Lukas Biomedical | 1.10B |